Cerenome, Inc. (CNSY)
2.25
-0.08
(-3.23%)
USD |
NASDAQ |
Sep 14, 10:51
Cerenome Total Liabilities (Quarterly) : 8.567M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.567M |
| March 31, 2026 | 7.955M |
| December 31, 2025 | 12.33M |
| September 30, 2025 | 13.62M |
| June 30, 2025 | 7.316M |
| March 31, 2025 | 35.70M |
| December 31, 2024 | 15.58M |
| September 30, 2024 | 12.15M |
| June 30, 2024 | 18.84M |
| March 31, 2024 | 10.46M |
| December 31, 2023 | 12.74M |
| September 30, 2023 | 10.66M |
| June 30, 2023 | 11.54M |
| March 31, 2023 | 12.96M |
| December 31, 2022 | 17.42M |
| September 30, 2022 | 11.70M |
| June 30, 2022 | 11.59M |
| March 31, 2022 | 9.874M |
| December 31, 2021 | 11.14M |
| September 30, 2021 | 9.995M |
| June 30, 2021 | 8.889M |
| March 31, 2021 | 8.823M |
| December 31, 2020 | 9.074M |
| September 30, 2020 | 9.032M |
| June 30, 2020 | 10.60M |
| Date | Value |
|---|---|
| March 31, 2020 | 20.88M |
| December 31, 2019 | 22.07M |
| September 30, 2019 | 25.56M |
| June 30, 2019 | 15.16M |
| March 31, 2019 | 20.76M |
| December 31, 2018 | 18.77M |
| September 30, 2018 | 19.39M |
| June 30, 2018 | 17.93M |
| March 31, 2018 | 18.16M |
| December 31, 2017 | 18.62M |
| September 30, 2017 | 18.63M |
| June 30, 2017 | 21.25M |
| March 31, 2017 | 22.41M |
| December 31, 2016 | 23.62M |
| September 30, 2016 | 23.17M |
| June 30, 2016 | 23.96M |
| March 31, 2016 | 25.17M |
| December 31, 2015 | 25.49M |
| September 30, 2015 | 37.45M |
| June 30, 2015 | 44.26M |
| March 31, 2015 | 60.24M |
| December 31, 2014 | 44.42M |
| September 30, 2014 | 35.61M |
| June 30, 2014 | 37.06M |
| March 31, 2014 | 37.02M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ernexa Therapeutics, Inc. | 3.115M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.03M |
| Shareholders Equity (Quarterly) | 5.463M |
| Debt to Equity Ratio | 0.0081 |
| Current Ratio | 1.346 |
| Net Debt Paydown Yield | 0.00% |